ATRA: Atara Biotherapeutics, Inc. Stock

by  •  • Comments Off on ATRA: Atara Biotherapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 39.17
Enterprise Value ($M) -7.29
Book Value ($M) -97.28
Book Value / Share -15.72
Price / Book -0.43
NCAV ($M) -141.49
NCAV / Share -24.56
Price / NCAV -0.28

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -0.80
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.40
Current Ratio 0.59

Balance Sheet (mrq) ($M)
Current Assets 64.89
Assets 109.10
Liabilities 206.38
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -83.44
Net Income -85.40
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -68.72
Cash from Investing 8.62
Cash from Financing 59.28

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-06 13G Panacea Innovation Ltd 9.50
11-14 13G/A Citadel Advisors Llc 4.60
11-14 13G/A EcoR1 Capital, LLC 9.99 -95.10
11-12 13G/A Vanguard Group Inc 3.18 0.00
09-13 13G/A Redmile Group, LLC 9.90 -94.37
09-05 13D/A Adiumentum Capital Fund I LP 19.99 -85.94
07-08 13G/A BlackRock, Inc. 0.00 -100.00
2024-02-14 13G/A Maverick Capital Ltd 0.00 -100.00
2024-02-09 13G/A Wasatch Advisors Inc

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-07 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-07 7,100 32,012 22.18
2025-03-06 4,936 29,098 16.96
2025-03-05 5,054 25,938 19.48
2025-03-04 10,407 63,563 16.37

(click for more detail)

Similar Companies
ARWR – Arrowhead Pharmaceuticals, Inc. ASMB – Assembly Biosciences, Inc.
ATHA – Athira Pharma, Inc. AVIR – Atea Pharmaceuticals, Inc.
AVXL – Anavex Life Sciences Corp.


Financial data and stock pages provided by
Fintel.io